Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Peyrade

Showing results (51-60 of 57) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 57 results.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|November 6, 2007
A comparison between distal and proximal port device insertion in head and neck cancerP-Y Marcy, E Chamorey, N Amoretti, et al.
Revue De Laryngologie - Otologie - Rhinologie|August 23, 2012
[Total pharyngolaryngectomy in the 21st century: indications, oncologic and functional outcomes]B Agopian, O Dassonville, E Chamorey, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 19, 2017
Hyperprogression during anti-PD-1/PD-L1 therapy in patients with recurrent and/or metastatic head and neck squamous cell carcinomaE Saâda-Bouzid, C Defaucheux, A Karabajakian, et al.
European Annals of Otorhinolaryngology, Head and Neck Diseases|November 15, 2012
Clinical and histological prognostic factors in locally advanced oral cavity cancers treated with primary surgeryN Vincent, O Dassonville, E Chamorey, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|August 21, 2009
[Neck dissection following chemoradiation for node positive head and neck carcinomas]J Thariat, M Hamoir, F Janot, et al.
European Annals of Otorhinolaryngology, Head and Neck Diseases|January 18, 2011
Head and neck free-flap reconstruction in the elderlyE E M Nao, O Dassonville, E Chamorey, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 26, 2014
Cisplatin, 5-fluorouracil, and cetuximab (PFE) with or without cilengitide in recurrent/metastatic squamous cell carcinoma of the head and neck: results of the randomized phase I/II ADVANTAGE trial (phase II part)J B Vermorken, F Peyrade, J Krauss, et al.
Pageof 6

Showing results (51-60 of 57) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 57 results.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|November 6, 2007
A comparison between distal and proximal port device insertion in head and neck cancerP-Y Marcy, E Chamorey, N Amoretti, et al.
Revue De Laryngologie - Otologie - Rhinologie|August 23, 2012
[Total pharyngolaryngectomy in the 21st century: indications, oncologic and functional outcomes]B Agopian, O Dassonville, E Chamorey, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 19, 2017
Hyperprogression during anti-PD-1/PD-L1 therapy in patients with recurrent and/or metastatic head and neck squamous cell carcinomaE Saâda-Bouzid, C Defaucheux, A Karabajakian, et al.
European Annals of Otorhinolaryngology, Head and Neck Diseases|November 15, 2012
Clinical and histological prognostic factors in locally advanced oral cavity cancers treated with primary surgeryN Vincent, O Dassonville, E Chamorey, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|August 21, 2009
[Neck dissection following chemoradiation for node positive head and neck carcinomas]J Thariat, M Hamoir, F Janot, et al.
European Annals of Otorhinolaryngology, Head and Neck Diseases|January 18, 2011
Head and neck free-flap reconstruction in the elderlyE E M Nao, O Dassonville, E Chamorey, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 26, 2014
Cisplatin, 5-fluorouracil, and cetuximab (PFE) with or without cilengitide in recurrent/metastatic squamous cell carcinoma of the head and neck: results of the randomized phase I/II ADVANTAGE trial (phase II part)J B Vermorken, F Peyrade, J Krauss, et al.
Pageof 6